We describe the construction of a panel data set from the U.S. patent data that contains measures of inventors' life-cycle R&D productivity--patents and patent citations. We match the data set to information on the U.S. pharmaceutical and semiconductor firms for whom they work. In this paper we use these data to examine the role of research personnel as a pathway for the diffusion of ideas from foreign countries to U.S. innovators. In particular, we find in recent years an increase in the extent that U.S. innovating firms collaborate with or employ researchers with foreign experience. This increase appears to work primarily through an increase in U.S. firms' employment of foreign-residing researchers; the fraction of research-active U.S. residents with foreign research experience appears to be falling, suggesting that U.S. pharmaceutical and semiconductor firms are increasingly locating operations in foreign countries to employ such researchers, as opposed to such researchers immigrating to the U.S. to work. In addition, we investigate which U.S. firms conducting R&D build upon innovations originating abroad. We find that employing or collaborating with researchers who have research experience abroad seems to facilitate the use of output of non-U.S. R&D. We also find that in the semiconductor industry smaller and older firms, and in the pharmaceutical industry, younger firms are more likely to access foreign R&D output.
externally-located technology partly through the hiring of and collaboration with researchers from the outside. Moreover, they find that hiring/collaboration with outside scientists is complementary to other means of accessing externally produced knowledge, such as through informal communications with outsiders and more formal (such as consulting) relationships with outsiders. Almeida and Kogut (1999) find that scientific references that firms cite in their patent applications reflect the employment histories of their inventors, suggesting that ideas in the semiconductor industry are spread by the movement of key engineers among firms, especially within a geographical area.
2 Zucker, Darby, and Armstrong (2001) find evidence of a pay-off to firms that seek interactions with outside researchers. They find a positive impact on patent productivity for biotech firms that collaborate with university researchers on research and scholarly publications.
We have constructed a scientist-based data set that will allow us to study the role of research personnel as a pathway for the diffusion of ideas, among other aspects of innovation.
This paper details the construction of these data and then describes their use in an analysis of the influence of foreign R&D on U.S. innovating firms. This paper is part of a larger project examining empirically issues related to the labor market for scientists.
The first half of the paper describes the construction of these data. The inventors behind the patented invention, as well as their home addresses, are listed on each U.S. patent, as are the firms to which the patent is assigned and the assignees' nationalities of incorporation. The firm to which the patent is assigned is in most cases the employer of the persons named in the 2 See also the (indirect) evidence of a link between scientific mobility and technological diffusion in Kim and Marschke (2005) and Moen (2005) . Kim and Marschke find that firms are more likely to patent in environments where scientists are more likely to switch employers, suggesting that workers do transmit technological know-how when they move from one employer to another. Technical knowledge acquired by the scientist that can be transmitted to future employers is a form of general human capital. Thus, like general human capital, scientists should pay to acquire technological knowledge that they can exploit possibly with multiple employers with lower wages. Moen finds some evidence of this: he shows that technical workers in R&D intensive firms in Norway accept lower wages early in their career in exchange for higher wages later.
inventor field. We match names in the inventor fields of patents to construct a panel data set of inventors that contains the patents in each year of the inventors' careers. The resulting data set allows us to track scientists geographically over the course of their career. These data afford us a window on the migration of technological human capital across national borders, one possible mechanism by which technology diffuses internationally. Patent applications disclose any knowledge they have of previous relevant inventions. Through its citations to previous patents each patent documents the "prior art" upon which the new innovation builds, and because we know each cited patent's assignee type, we know in which sector and country the prior art originated. These citations provide an additional window on the pathways of knowledge. In the final stage of constructing our patent-inventor data set we merge in citations made by the patent for each patent to which the inventor is named.
One use to which we wish to put our data is in understanding the factors that influence the innovating firm's accessing of recent innovations developed externally. A focus of this part of the analysis is the pharmaceutical and semiconductor industries, two industries that are especially prolific generators of innovations and patents. Thus the last stage of data construction involves carefully matching the inventor data to data on publicly traded firms in these two industries.
After detailing our data construction efforts, we put our data to use investigating the international transmission of technology through scientific labor markets. For each patent assigned to a U.S. firm, we can determine the country of the inventor's residence at the time of patent application, and whether they had ever been named as an inventor on a patent while residing abroad. Inventing in a foreign country can be regarded as evidence of an inventor's exposure to research abroad. We also investigate which U.S. firms in our two industries cite foreign-assigned patents as prior art and thus build upon innovations originating abroad.
Our main findings are the following. We find that there has been an increase in recent years of U.S. innovating firms employing or collaborating with researchers with foreign experience. This increase appears to work primarily through an increase in U.S. firms' employment of foreign-residing researchers; the fraction of research-active U.S. residents with foreign research experience appears to be falling, suggesting that U.S. pharmaceutical and semiconductor firms are going to foreign countries to employ such researchers as opposed to such researchers immigrating to the U.S. to work for U.S. firms. In addition we investigate the firm-level determinants of accessing non-U.S. technological know-how. We find, for example, that employing or collaborating with researchers with research experience abroad seems to facilitate this access. Also, in the semiconductor industry, smaller and older firms and in the pharmaceutical industry, younger firms are more likely to make use of the output of non-U.S.
R&D.
The paper is organized as follows. Sections 2 and 3 describe the sources for the data construction and the construction itself. Section 4 details some descriptive statistics of the data set. Section 5 describes our analysis on the influence of foreign R&D on U.S. innovation.
Section 6 concludes.
Data Sources
The data set we have created contains measures-patents and patent citations-of the R&D productivity of individual researchers between 1975 and 1998 and includes information on their advanced degrees in the natural sciences and engineering fields. These data also contain, for patents assigned to publicly traded firms in the U. and Corptech data which report a firm's founding year, and finally (6) the NBER PatentCitations data collected by Hall, Jaffe and Trajtenberg (2001) , which contain all citations made by patents granted in . These data sources are described in detail below and variables used in our study from each data source are in Table 1 .
Patent Bibliographic data (Patents BIB)
Patents BIB is one of the Cassis Series of optical disc products released by the U.S.PTO.
Patents BIB contains bibliographic information for U.S. utility patents issued since January 1969. The mean citations received by a patent in these two industries is 8.13, ranging from a minimum of 1 and a maximum of 631.
Data Set Construction Process
This section discusses key issues that arise in assembling our data set from these six (2) one name from the pair is an inventor of a patent that is cited by another patent whose inventors include the other name from the pair; or (3) the two names from the pair share the same co-inventor. These three criteria in our name matching method are similar to the "Strong" criteria of Trajtenberg (2004) .
SOUNDEX is a coded index for last names based on the way a last name sounds in English rather than the way it is spelled. Last names that sound the same, but are spelled differently, like SMITH and SMYTH, have the same SOUNDEX code. We use the SOUNDEX coding method to expand the list of similar last names to overcome the potential for misspellings and inconsistent foreign name translations to English; misspellings are common in the U.S.PTO data as are names of non-Western European origin (see Appendix A for the detailed SOUNDEX coding method).
We also consider a pair of names as a match if two have the same full last and first names, and at least one of the following two conditions is met: (1) the two have the same zip code; or (2) they have the same full middle name. These two criteria correspond to the "Medium" criteria of Trajtenberg (2004) . As an additional step beyond the aforementioned pair-wise comparisons, we treat a pair of inventors as mismatched if the middle name initials of the pair are different. Table 2 illustrates our name-matching procedure. Inventors 001 and 002 in Table 2 have the same last and first names, and share the same co-inventor. Thus, the two records in this pair are treated as the same inventor. Inventors 002 and 003 do not have the same full middle name but share the same zip code, and thus the two inventors are treated as the same inventor.
Although inventors 002 and 005 share the same zip code, the middle name initials are different.
Therefore, the pair is not considered a match (they would not be considered a match by our algorithm even if their street addresses were identical, possibly a case of a parent and a child).
Imposing transitivity
Transitivity is imposed in the following sense: If name A is matched to name B and name B is matched to name C, name A is then matched to name C. We iterate this process until all possible transitivity matches are completed. After the transitivity procedure, we assign the same of these cases, we found the mismatches are of three kinds. In the first kind, some middle names in the Patents BIB data are incorrectly coded. For instance, our transitivity procedure matched the names 'Laszlo Andra Szporny' and 'Laszlo Eszter Szporny' which appear to belong to the same inventor according to other information. We found that this particular inventor does not have a middle name, and the middle names attributed to him were in fact the first names of the next co-inventors listed on his patents. In the second kind of mismatch, an inventor with two middle names is coded in the Patents BIB data with one middle name in some cases and with the other middle name in other cases. In the third kind, a mismatch occurs when two inventors with the same last and first name but different middle names appear in the same patent. We corrected by hand instances of the first two kinds of mismatch, but dropped from our data the observations displaying the third kind of mismatch.
Trajtenberg (2004) assigns scores for each matching criterion and considers a pair matched only if its total score from all matching criteria exceeds a threshold. Because the choice of weights and the score threshold for a match is largely arbitrary, we do not use this scoring method in our data construction. Our method also differs in that we do not use as a matching criterion whether two inventors share the same assignee because name matching based on this criterion might bias our measure of mobility among inventors. Instead we apply the rule that two inventors are not treated as a match if their middle name initials differ. From our experience with the patent data, imposing this rule is effective because the SOUNDEX coding system sometimes so loosely specifies names that apparently different last names are considered a match.
In the end, because of these differences, the number of distinct inventors identified with our procedure is a little higher than the number of distinct inventors reported in Trajtenberg assignees and 37.4% were granted to foreign assignees (see Table 3 ). In Figure 2 , we report the number of patents granted to firms in each of our two industries. Note that in both industries the number of patents granted annually rose over the period we study: the annual number of patents granted between 1989 and 1998 rose from about one thousand patents annually, but by a factor of two in the pharmaceutical industry and nearly seven in the semiconductor industry. Table 4 shows that the number of inventors named as an inventor to at least one patent assigned to a firm in one of our two industries is 59,292 out of the 2,299,579 unique inventors in our data (25,609 inventors in the pharmaceutical and 33,683 in the semiconductor industry). The percentage of master's or higher-degree holders in natural science and engineering is relatively higher in these two industries. Among the 2,299,579 unique inventors in our data, 5.3% hold masters or higher degrees (3% of inventors hold a Ph.D. or equivalent). Among the inventors in the pharmaceutical and semiconductor industries, 13.3% and 11.7%, respectively, hold an advanced degree.
Inventors working in these pharmaceutical and semiconductor industries are named as inventors on more patents on average than inventors in other industries (see Table 4 ). An inventor in a pharmaceutical firm is named as an inventor on average on 2.80 patents over our sample period, whereas an inventor in the semiconductor industry appears on average on 2.60 patents. Inventors with advanced degrees are shown in Table 4 to have more patents than those without advanced degrees. While advanced-degree holders in the pharmaceutical industry are more productive in patent output, those in the semiconductor industry appear to be similar in patent productivity to advanced-degree holders in other industries.
We identified pharmaceutical and semiconductor firms in the Compact D/SEC data by their primary SIC. We identified 447 parent firms and 5,331 subsidiary firms in the pharmaceutical industry and 332 parent firms and 4,211 subsidiary firms in the semiconductor industry. Firm information period is from 1989 because we had access to only the Compact D/SEC data beginning in 1989. We then dropped all patent applications filed after 1997 because we found that starting with application year 1998 the patent time series tailed off due to the review lag at the U.S.PTO.
Some sample statistics from the firms in the two industries in our data-the number of selected firms and the number of employees, sales, and R&D expenditures-are reported in 
International Knowledge Flow
In this section, we test if the international migration of researchers facilitates knowledge transfers across borders. Understanding the consequences of the immigration of scientists and researchers to the U.S.-on not only for U.S. R&D productivity but for the wages and job prospects of native workers and for national security-has important implications for policymaking in the immigration, labor market, and education arenas. Understanding how knowledge spillovers across countries work is of interest because of the role spillovers may play in economic growth and because of its implications for science and technology policy. Knowledge spillovers from the U.S. and Europe may be an important factor for the impressive growth rates enjoyed in countries such as South Korea and Taiwan (Hu and Jaffe, 2003) . As described in this paper's introduction, work done with patent citations suggests that knowledge flows may be geographically localized (Jaffe, Trajtenberg, and Henderson, 1993) . Some researchers have used patent citations to try to understand these international knowledge spillovers (Jaffe and Trajtenberg, 1998) . We use the geographic mobility of scientists to track the transmission of foreign knowledge from other countries to the U.S. and to obtain a better estimate of the importance of international scientific labor markets as a mechanism of technological transmission than has been possible previously. Table 6 shows the annual number of unique inventors named on U.S. domestic patents for the years 1985 through 1997. It also shows the percentage of inventors who (1) at the time of the patent application resided in a foreign country, (2) at the time of the patent application resided in the U.S. and had been previously listed as a foreign-residing inventor on a successful patent application, and (3) at the time of the patent application resided in the U.S. but had never been previously listed as a foreign residing inventor on a successful patent application. Because our data included patents granted in 1975 and later, we imposed a cut-off for the patents used to define whether an inventor has foreign-experience at the time of the patent's application. We chose to consider only those inventors who are currently foreign residents or had been foreign residents some time in the ten-year period prior to the date of the patent's application because ten years still leaves us a long period over which to conduct our analysis and because knowledge acquired in a foreign country far in the past may not be very valuable. Table 6 shows a steady and swift increase in the number of unique inventors on U.S. Table 6 shows that the growth in the number of inventors in the pharmaceutical (13 percent annually) and semiconductor (31 percent annually) industries has been significantly faster than for all industries combined. In the pharmaceutical industry the share of inventors with foreign experience grew rapidly although the increase is mostly in the share of inventors with current foreign addresses and there is a decrease in the fraction of U.S.-residing inventors with past foreign experience. This finding is not surprising given the increasing rate at which U.S.
pharmaceutical firms have been citing new laboratories abroad (Chacar and Lieberman, 2003) and findings that collaborations among academic scientists have become more dispersed, possibly due to improvements in telecommunications (Adams, Black, Clemmons, and Stephan, 2004 ). The semiconductor industry shows a similar pattern, but the changes are less pronounced than in pharmaceutical industry. Figure 3A shows the average patent productivity of inventors in U.S. domestic patents by foreign-experience type for all patents. We first note that U.S.-residing inventors with past foreign experience have significantly higher patent-inventor ratio than other types of inventors.
There are at least two reasons for this. First, inventors with higher productivity are more likely to migrate to the U.S. because of better compensation in the U.S. labor market or because of U.S.
immigration policies. Alternatively, foreign experience somehow improves the productivity of researchers. Both the patent-inventor ratios for current foreign residents and for current U.S.
residents without foreign experience show a similar level. Figure 3A also shows that the patent productivity for inventors with past foreign experience was steady at around 1.6 patents per inventor until 1993 and then it rose to 2 patents per inventor in 1997. On the other hand, the patent-inventor ratios for other types of inventors were stable or declined slightly over the period. Figure 4C does show that foreign-residing inventors produce the lowest quality patents, by the citation measure.
Is a patent more likely to cite foreign-assignee patents when its inventors have foreign experience? We are interested in learning if knowledge spillovers from foreign countries are facilitated by direct exposure to inventors with foreign experience. Table 8 presents the results of our estimation of the determinants of accessing foreign knowledge in two industries:
pharmaceutical and semiconductor industry. The unit of observation of the regression is a patent applied for in year 1997. The dependent variable is the logit transformation of the fraction of citations to patents that are assigned to foreign assignees (CITE_FRGN). The key regressor in these regressions is a binary variable which takes 1 if at least one inventor on the patent is currently residing or formerly resided in one of the foreign countries where foreign assignees of cited patents are located (FRGN_EXP). Note that this regressor reflects not just whether an inventor has foreign experience but which country the inventor has experience from. We speculate that knowledge spillover is country-specific.
The regressions in Table 8 Table 7 .
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Column 1 in Table 8 for each industry panel shows the estimated relationship between the fraction of a patent's citations to foreign-assigned patents and the existence of foreignexperienced inventors using OLS. Column 2 for each industry panel reports the estimates of the determinants of the citation to foreign patents.
One concern for our regression is that inventors are more likely to cite their own past patents than other inventors' patents, which may drive the estimated relationship between our dependent variable and the key regressor, FRGN_EXP. In column 3 for each industry panel we thus exclude patents which have the same inventors as those in their cited patents.
The results in Table 8 show that a patent by inventors with foreign experience in both industries is more likely to cite patents assigned to foreign firms from the same country where the inventors are residing or resided in the past: FRGN_EXP has a significantly positive effect in all models. This effect is still significant with the data without self-citing patents.
The results show a negative effect of the size of the R&D enterprise on the fraction of citations to foreign patents in the semiconductor industry. There is no significant effect of the size of the R&D enterprise in the pharmaceutical industry. On the other hand, the coefficient estimate on the firm size variable (EMPLOYEE) is insignificant in all models. The coefficient estimate on logR&D/INV is generally positive but insignificant in all regressions. The coefficient estimate on log NSIC is never significant by conventional criteria of significance.
The coefficient estimate on log MEXP is negative and significant for both industries. This may partly reflect that it is more costly for older inventors to learn new technologies from abroad, or 9 Note that the means of the variables reported in table 7 are not the averages across firms because our regressions are at the patent level, not at the firm level. For instance, the mean value of INVENTOR and EMPLOYEE is greater than the firm mean in 1997 because larger firms tend to have more patents.
it may be due to a vintage or a composition effect (e.g., areas of technology that experienced innovators innovate in are somehow more "domestic"). The coefficient estimate on log FIRMAGE is significant for both industries but has different signs for the two industries. The effect is negative in pharmaceutical industry while it is positive in semiconductor industry. That is, we find that in the semiconductor industry older firms, and in the pharmaceutical industry, younger firms are more likely to make use of the output of non-U.S. R&D.
Conclusion
We describe the construction of a panel data set that links inventors to the U.S.
pharmaceutical and semiconductor firms for whom they work. These data contain measures of inventors' R&D productivity-patents and patent citations-as well as information on the firms to which their patents are assigned. In this paper we use these data to examine the role of research personnel as a pathway for the diffusion of ideas from foreign to U.S. innovators. In particular, we find in recent years an increase in the extent that U.S. innovators employ or collaborate with researchers with foreign R&D experience. This increase appears to work primarily through an increase in U.S. firms' employment of foreign-residing researchers; the fraction of research-active U.S. residents with foreign research experience appears to be falling, suggesting that U.S. pharmaceutical and semiconductor firms are increasingly locating operations in foreign countries to employ such researchers, as opposed to such researchers immigrating to the U.S. to work. In addition we investigate the firm-level determinants of accessing non-U.S. technological know-how, as measured by the prevalence of citations to patents on innovations originating outside the U.S. We find that employing researchers who have research experience abroad seems to facilitate this access. We also find that in the semiconductor industry smaller and older firms, and in the pharmaceutical industry, younger firms are more likely to make use of the output of non-U.S. R&D.
We anticipate this data set will be useful in addressing other important questions. These data will allow us to investigate the consequences of the mobility of R&D personnel on firm R&D. What is the impact, for example, of the arrival of a researcher with a particular set of R&D experiences on the character and quantity R&D done by a firm? We will be able to address this question because we know each scientist's patenting history, both in terms of quantity but we also know the kinds of technologies underlying the innovations. This data set will allow us to directly observe the importance of inter-firm mobility for technological diffusion.
From the perspective of the scientist, this data set will allow us to examine the determinants of inter-firm mobility. The panel nature of these data will allow us to investigate the productivity profiles of researchers working in industry over their careers. Because we observe all the inventors responsible for a patent we will be able to use this data set to investigate how firms organize the R&D enterprise, the extent of collaboration among scientists who are geographically dispersed, and the extent of interaction among scientists with different backgrounds. 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Year 5 1989 1990 1991 1992 1993 1994 1995 1996 1997 Year P aten ts p er In ven to r Rows show the estimated coefficient and the t statistic for each regressor. The result for a constant term is suppressed. Column 3 shows the results from a regression that omits patents for which an inventor is listed as an inventor on a cited patent. The t statistic is based on the Huber-White sandwich estimator of variance.
